Medicine and Dentistry
Neoplasm
100%
Breast Carcinoma
35%
Endometrium Carcinoma
32%
Metastatic Carcinoma
27%
Breast Cancer
26%
Colorectal Carcinoma
24%
Carcinoma
22%
Gene Mutation
22%
Exon
21%
Cancer Model
18%
Protein P53
18%
Microsatellite Instability
16%
Neoadjuvant Therapy
15%
Overall Survival
15%
Primary Tumor
15%
Triple Negative Breast Cancer
14%
Beta-Catenin
12%
Biological Marker
10%
Fine-Needle Aspiration
9%
Biopsy Technique
9%
Multivariate Analysis
9%
Epidermal Growth Factor Receptor
9%
Malignant Neoplasm
9%
down Regulation
8%
Krukenberg Tumor
8%
Disease Free Survival
8%
Low Density Lipoprotein Receptor Related Protein
8%
Phosphatase
8%
Ovarian Cancer
8%
Adenosarcoma
8%
Tensin
8%
Stem Cell
8%
Cancer Cell
8%
Cancer Specific Survival
8%
Dilated Cardiomyopathy
8%
Uvomorulin
8%
Endometrioid Carcinoma
8%
Somatomedin C Receptor
8%
Heart Ventricle Remodeling
8%
Transcription Factor GATA 3
8%
Phosphotransferase
8%
Soft Tissue Sarcoma
8%
Squamous Cell Carcinoma
8%
Neoadjuvant Chemotherapy
8%
Osteonectin
8%
Trastuzumab
8%
Tachyarrhythmia
8%
Tumor Necrosis Factor Receptor Superfamily Member 6
8%
Phosphoinositide 3-Kinase
8%
Adenofibroma
8%
Keyphrases
Tumor
66%
C-X-C Chemokine Receptor Type 4 (CXCR4)
28%
Endometrial Carcinoma
27%
Breast Carcinoma
27%
Colorectal Cancer Model
26%
PIK3CA mutation
23%
Exon 20
19%
PIK3CA
18%
Molecular Genetics
18%
Metastasis
17%
Microsatellite Instability-high (MSI-H)
17%
Human Epidermal Growth Factor Receptor 2 (HER2)
16%
HER2-negative Breast Cancer
16%
Genetic Modification
16%
Estrogen
13%
Neoadjuvant Therapy
12%
Primary Tumor
12%
Non-endometrioid
12%
Beta-catenin
12%
Ki-67
12%
Metastatic Efficiency
11%
Triple-negative Breast Carcinoma
11%
Overexpression
11%
Prognostic Factors
11%
CXCR4 Expression
11%
Endometrioid
10%
Overall Survival
10%
Immunohistochemical Study
10%
Exon 9
10%
Metastatic Dissemination
10%
Prognostic Significance
9%
Multivariate Analysis
9%
Endometrioid Adenocarcinoma
9%
Deregulation
9%
Clinical Significance
9%
K-ras
9%
CTNNB1
9%
Poor Prognosis
8%
Prognostic Biomarker
8%
Carcinoma
8%
Biofabrication
8%
Human Colorectal Cancer
8%
Selective Depletion
8%
Orthotopic Injection
8%
G12V
8%
Luminal Breast Cancer
8%
Independent Primary
8%
WT-1
8%
Biophysical Markers
8%
PAX8
8%